Document is current
Any future updates will be listed below
-
Authors
Mendoza, Michael F.
Anzelmo, Michael A.
Suan, Nina M.
Fourchy, Marie-Claire
Lavie, Carl J.
- License Information
-
More Information
Article History
Received: 13 January 2026
Accepted: 12 February 2026
First Online: 25 February 2026
Declarations
:
: No studies involving human participants or animals were conducted by the authors for this review article. All data discussed are derived from previously published studies that complied with recognized ethical standards.
: Dr. Lavie reports being on a data and safety monitoring board for Novo Nordisk for their REDEFINE 3 Trial with CagriSema (but in adults). The other authors declare that they have no conflicts of interest to disclose.
